Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_615868e873ace41aed29748a804fb749 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7040b8510902db50099146f807f4d02 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-108 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
filingDate |
2015-08-07^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e701bf7b699d439dccc747aa8552878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a118451a98fdedc07339b5e3d3fac440 |
publicationDate |
2020-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10751444-B2 |
titleOfInvention |
Flowable hemostatic gel composition and its methods of use |
abstract |
A method of inhibiting bleeding from an open surgical site includes mixing (i) a flowable gel solution comprising a biopolymer dissolved in a first solvent and (ii) a flowable hardener solution comprising a cross-linking agent dissolved in a second solvent to form a flowable hemostatic gel composition. The method also includes applying the flowable hemostatic gel composition to the open surgical site. The cross-linking agent links chains of the biopolymer together to form a solid hydrogel that inhibits bleeding from the surgical site. |
priorityDate |
2015-08-07^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |